ADCYAP1 and bipolar disorder: These findings suggest that PACAP signaling might be involved in the pathogenesis of multiple mental disorders, such as bipolar disorder, major depressive disorder, schizophrenia, PTSD, and attention-deficit/hyperactivity disorder (ADHD).